These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. A comparison of transcriptomic and metabonomic technologies for identifying biomarkers predictive of two-year rodent cancer bioassays. Thomas RS, O'Connell TM, Pluta L, Wolfinger RD, Yang L, Page TJ. Toxicol Sci; 2007 Mar; 96(1):40-6. PubMed ID: 17114358 [Abstract] [Full Text] [Related]
24. Oxidative Stress Mechanisms Do Not Discriminate between Genotoxic and Nongenotoxic Liver Carcinogens. Deferme L, Wolters J, Claessen S, Briedé J, Kleinjans J. Chem Res Toxicol; 2015 Aug 17; 28(8):1636-46. PubMed ID: 26198647 [Abstract] [Full Text] [Related]
25. Active cell death (apoptosis) and cellular proliferation as indicators of exposure to carcinogens. Schulte-Hermann R, Bursch W, Marian B, Grasl-Kraupp B. IARC Sci Publ; 1999 Aug 17; (146):273-85. PubMed ID: 10353391 [Abstract] [Full Text] [Related]
26. Comparison of primary human hepatocytes and hepatoma cell line Hepg2 with regard to their biotransformation properties. Wilkening S, Stahl F, Bader A. Drug Metab Dispos; 2003 Aug 17; 31(8):1035-42. PubMed ID: 12867492 [Abstract] [Full Text] [Related]
27. Characteristic expression profiles induced by genotoxic carcinogens in rat liver. Ellinger-Ziegelbauer H, Stuart B, Wahle B, Bomann W, Ahr HJ. Toxicol Sci; 2004 Jan 17; 77(1):19-34. PubMed ID: 14600272 [Abstract] [Full Text] [Related]
28. Comparison of Drug Metabolism and Its Related Hepatotoxic Effects in HepaRG, Cryopreserved Human Hepatocytes, and HepG2 Cell Cultures. Yokoyama Y, Sasaki Y, Terasaki N, Kawataki T, Takekawa K, Iwase Y, Shimizu T, Sanoh S, Ohta S. Biol Pharm Bull; 2018 May 01; 41(5):722-732. PubMed ID: 29445054 [Abstract] [Full Text] [Related]
31. The human hepatoma HepaRG cells: a highly differentiated model for studies of liver metabolism and toxicity of xenobiotics. Guillouzo A, Corlu A, Aninat C, Glaise D, Morel F, Guguen-Guillouzo C. Chem Biol Interact; 2007 May 20; 168(1):66-73. PubMed ID: 17241619 [Abstract] [Full Text] [Related]
34. Expression of cytochromes P450, conjugating enzymes and nuclear receptors in human hepatoma HepaRG cells. Aninat C, Piton A, Glaise D, Le Charpentier T, Langouët S, Morel F, Guguen-Guillouzo C, Guillouzo A. Drug Metab Dispos; 2006 Jan 20; 34(1):75-83. PubMed ID: 16204462 [Abstract] [Full Text] [Related]
35. Quantitative comparison of in vitro genotoxicity between metabolically competent HepaRG cells and HepG2 cells using the high-throughput high-content CometChip assay. Seo JE, Tryndyak V, Wu Q, Dreval K, Pogribny I, Bryant M, Zhou T, Robison TW, Mei N, Guo X. Arch Toxicol; 2019 May 20; 93(5):1433-1448. PubMed ID: 30788552 [Abstract] [Full Text] [Related]
36. RNA-Seq provides new insights in the transcriptome responses induced by the carcinogen benzo[a]pyrene. van Delft J, Gaj S, Lienhard M, Albrecht MW, Kirpiy A, Brauers K, Claessen S, Lizarraga D, Lehrach H, Herwig R, Kleinjans J. Toxicol Sci; 2012 Dec 20; 130(2):427-39. PubMed ID: 22889811 [Abstract] [Full Text] [Related]
37. A comparison of whole genome gene expression profiles of HepaRG cells and HepG2 cells to primary human hepatocytes and human liver tissues. Hart SN, Li Y, Nakamoto K, Subileau EA, Steen D, Zhong XB. Drug Metab Dispos; 2010 Jun 20; 38(6):988-94. PubMed ID: 20228232 [Abstract] [Full Text] [Related]
38. Effect of aflatoxin B1, benzo[a]pyrene, and methapyrilene on transcriptomic and epigenetic alterations in human liver HepaRG cells. Tryndyak V, Kindrat I, Dreval K, Churchwell MI, Beland FA, Pogribny IP. Food Chem Toxicol; 2018 Nov 20; 121():214-223. PubMed ID: 30157460 [Abstract] [Full Text] [Related]
39. Identification of potential biomarkers of genotoxicity and carcinogenicity in L5178Y mouse lymphoma cells by cDNA microarray analysis. Kim JY, Kwon J, Kim JE, Koh WS, Chung MK, Yoon S, Song CW, Lee M. Environ Mol Mutagen; 2005 Nov 20; 45(1):80-9. PubMed ID: 15612046 [Abstract] [Full Text] [Related]
40. Comparison of phenotypic and transcriptomic effects of false-positive genotoxins, true genotoxins and non-genotoxins using HepG2 cells. Magkoufopoulou C, Claessen SM, Jennen DG, Kleinjans JC, van Delft JH. Mutagenesis; 2011 Sep 20; 26(5):593-604. PubMed ID: 21632981 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]